‘The man who saved the world’: is AstraZeneca’s boss worth his millions?
Pascal Soriot’s bonus might be deserved, but that doesn’t mean it’s necessarily wise
There can’t be many company bosses in Britain, or elsewhere in the world, “more deserving of a decent bonus this year than AstraZeneca’s Pascal Soriot”, said Ben Marlow in The Daily Telegraph. No other pharmaceutical giant pledged to produce a jab on a not-for-profit basis, and Astra’s AZD1222 has been “pivotal in turning the tide” against a disease that has infected 160 million and killed 3.3 million worldwide.
Yet, incredibly, the company’s plans to reward its French boss have encountered “a storm of protest” from shareholders aghast at plans to hike his pay package from £15.4m to a maximum of £17.8m. The “faceless” but influential Investment Association waded in with a so-called “amber-top” warning – its second highest level of alert. Institutional investors Aviva and Standard Life Aberdeen (soon to be rebranded as Abrdn) both voted against the proposals, along with 40% of other investors at this week’s AGM. So Soriot will get his bonus – but he gets an undeserved punch on the nose too.
“Seconds out. In the blue corner, the man who saved the world. In the red? A bunch of corporate governance box-tickers. Who would you want to win,” asked Alistair Osborne in The Times. In fairness, this row was “a bit more nuanced than that”. Astra has “naughtily flouted” a City rule that changes to pay policy must be “three-year, not annual” events. Moreover, bumping up Soriot’s potential bonus to 900% of his £1.33m salary is unheard of at a big FTSE 100 group, and “comes perilously close to the symbolic no-no of 1,000%”. Still, “rules are there to be broken”.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.
Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
It’s hard to argue that Soriot’s contribution isn’t worth £18m: his brave gamble on the Astra/Oxford jab “is the key reason for Britain’s faster Covid recovery”. What’s more, Astra shareholders have had £30bn of capital value since Soriot rejected Pfizer’s takeover bid in 2014. “Throwing big money at your top team might look insensitive” amid a painful pandemic, said Lee Wild of Interactive Investor on ii.co.uk – but too many executives get rewarded for failure. Pascal Soriot isn’t one of them.
Funnily enough, said Helen Thomas in the FT, “it turns out the system can’t really cope with paying for success either”. And there’s the rub, said Patrick Hosking in The Times. Executive pay is “like an arms race”, and Soriot’s 900% will set “a new benchmark” for good and poor performers alike. Astra investors had an unattractive choice between “disloyalty to a world-beating company”, and “opening the floodgates to more opportunistic, precedent-smashing, norm-flouting pay proposals”. A pity Soriot couldn’t “settle for a knighthood instead”.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
The Pentagon faces an uncertain future with Trump
Talking Point The president-elect has nominated conservative commentator Pete Hegseth to lead the Defense Department
By Justin Klawans, The Week US Published
-
This is what you should know about State Department travel advisories and warnings
In Depth Stay safe on your international adventures
By Catherine Garcia, The Week US Published
-
'All Tyson-Paul promised was spectacle and, in the end, that's all we got'
Instant Opinion Opinion, comment and editorials of the day
By Justin Klawans, The Week US Published
-
Could 'adult dorms' save city downtowns?
Today's Big Question 'Micro-apartments' could relieve office vacancies and the housing crisis
By Joel Mathis, The Week US Published
-
Why are America's restaurant chains going bankrupt?
Today's Big Question Red Lobster was the first. TGI Fridays might be next.
By Joel Mathis, The Week US Published
-
Is flexible working better for business?
Today's Big Question Labour wants to end 'culture of presenteeism' and make hybrid working a 'default right' for UK employees
By Richard Windsor, The Week UK Published
-
'Super Mario' to the rescue: can Draghi fix Europe's economy?
Today's Big Question Former central bank boss calls for more innovation and investment – but faces 'too many moving parts for a straightforward fix'
By Elliott Goat, The Week UK Published
-
Why are older workers staying on the job?
Today's Big Question And what does it mean for younger workers?
By Joel Mathis, The Week US Published
-
Can Starbucks' new CEO revive the company?
Today's Big Question Brian Niccol has been the CEO of Chipotle since 2018 but is now moving to the coffee chain
By Justin Klawans, The Week US Published
-
Is the Fed ready to start cutting interest rates?
Today's Big Question Recession fears and a presidential election affect the calculation
By Joel Mathis, The Week US Published
-
Why are global stock markets plunging?
Today's Big Question Europe, Asia and Wall Street have all suffered big falls after US economy data spooked investors
By Rebekah Evans, The Week UK Published